[{"id":"abd76cdb-12d9-4904-9a08-3b3400169164","acronym":"","url":"https://clinicaltrials.gov/study/NCT02993146","created_at":"2021-01-29T07:13:49.401Z","updated_at":"2024-07-02T16:35:11.807Z","phase":"Phase 1","brief_title":"Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases","source_id_and_acronym":"NCT02993146","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ropidoxuridine (IPdR)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 11","initiation":"Initiation: 05/08/2017","start_date":" 05/08/2017","primary_txt":" Primary completion: 08/19/2022","primary_completion_date":" 08/19/2022","study_txt":" Completion: 09/22/2024","study_completion_date":" 09/22/2024","last_update_posted":"2024-04-02"},{"id":"6546b0c5-710f-4af5-b959-a7792033251c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02381561","created_at":"2021-01-29T07:07:48.027Z","updated_at":"2024-07-02T16:35:15.997Z","phase":"Phase 1","brief_title":"Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy","source_id_and_acronym":"NCT02381561","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ropidoxuridine (IPdR)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 19","initiation":"Initiation: 02/01/2016","start_date":" 02/01/2016","primary_txt":" Primary completion: 11/08/2018","primary_completion_date":" 11/08/2018","study_txt":" Completion: 03/05/2025","study_completion_date":" 03/05/2025","last_update_posted":"2024-03-07"}]